About CBT
Cambridge Biotechnology Ltd (CBT) is a wholly owned subsidiary of Biovitrum AB (publ). The company's founders originate from
a Pfizer Global Research & Development drug discovery team in
what had previously been the Parke-Davis Neuroscience Research Centre.
The founders, together with some key academic collaborators, created
the company to exploit several opportunities in drug discovery as
well as their world class "gene to lead" drug discovery
capability.
The company has well equipped modern laboratory and office facilities
situated on the Babraham Research Campus.
This location allows the company to forge links with a host of world
class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures.
|
